Patient-reported outcomes enhance understanding of the impact of pazopanib in soft tissue sarcoma

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2868-2870

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2868-2870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pazopanib: In Advanced Soft Tissue Sarcoma

By Deeks Emma D.  

Drugs, Vol. 72, Iss. 16, 2012-11 ,pp. : 2129-2140

Adis International

Access to resources Recommend Favorite

Patient-Reported Outcomes in Multiple Myeloma

By Lee Stephanie J.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 4, 2004-07 ,pp. : 379-383

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pathology of Soft Tissue Sarcoma

By Rubin Brian P.   Goldblum John R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 4, 2007-04 ,pp. : 411-418

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Soft Tissue Sarcoma Guidelines

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 4, 2007-04 ,pp. : 364-410

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Joint Modeling of Multiple Longitudinal Patient-Reported Outcomes and Survival

By Hatfield Laura A.  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 5, 2011-09 ,pp. : 971-991

Taylor & Francis Ltd

Access to resources Recommend Favorite